Medtronic PLC (2M6) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (2M6) has a cash flow conversion efficiency ratio of 0.051x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.57 Billion ≈ $3.01 Billion USD) by net assets (€50.07 Billion ≈ $58.54 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Medtronic PLC for the company's overall valuation and market capitalisation.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2026)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency. Explore 2M6 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Johnson Controls International PLC
NYSE:JCI
|
0.118x |
|
Brookfield Corporation
TO:BN
|
0.018x |
|
Ping An Insurance Group Co of China Ltd
SHG:601318
|
0.001x |
|
Barclays PLC
MX:BCSN
|
N/A |
|
Westpac Banking Corporation
AU:WBC
|
0.157x |
|
American Tower Corp
NYSE:AMT
|
0.135x |
|
MercadoLibre Inc.
NASDAQ:MELI
|
0.285x |
|
NetEase Inc
MX:NTESN
|
0.080x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2026)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2026. View current stock price of Medtronic PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-04-30 | €50.07 Billion ≈ $58.54 Billion |
€7.33 Billion ≈ $8.57 Billion |
0.146x | +0.28% |
| 2025-04-30 | €48.26 Billion ≈ $56.42 Billion |
€7.04 Billion ≈ $8.24 Billion |
0.146x | +8.44% |
| 2024-04-30 | €50.42 Billion ≈ $58.95 Billion |
€6.79 Billion ≈ $7.93 Billion |
0.135x | +15.16% |
| 2023-04-30 | €51.66 Billion ≈ $60.40 Billion |
€6.04 Billion ≈ $7.06 Billion |
0.117x | -16.11% |
| 2022-04-30 | €52.72 Billion ≈ $61.64 Billion |
€7.35 Billion ≈ $8.59 Billion |
0.139x | +15.22% |
| 2021-04-30 | €51.60 Billion ≈ $60.33 Billion |
€6.24 Billion ≈ $7.30 Billion |
0.121x | -14.96% |
| 2020-04-30 | €50.87 Billion ≈ $59.47 Billion |
€7.23 Billion ≈ $8.46 Billion |
0.142x | +1.90% |
| 2019-04-30 | €50.21 Billion ≈ $58.70 Billion |
€7.01 Billion ≈ $8.19 Billion |
0.140x | +51.41% |
| 2018-04-30 | €50.82 Billion ≈ $59.42 Billion |
€4.68 Billion ≈ $5.48 Billion |
0.092x | -32.46% |
| 2017-04-30 | €50.42 Billion ≈ $58.94 Billion |
€6.88 Billion ≈ $8.04 Billion |
0.136x | +35.54% |
| 2016-04-30 | €51.83 Billion ≈ $60.59 Billion |
€5.22 Billion ≈ $6.10 Billion |
0.101x | +9.33% |
| 2015-04-30 | €53.23 Billion ≈ $62.23 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.092x | -63.89% |
| 2014-04-30 | €19.44 Billion ≈ $22.73 Billion |
€4.96 Billion ≈ $5.80 Billion |
0.255x | -2.48% |
| 2013-04-30 | €18.67 Billion ≈ $21.83 Billion |
€4.88 Billion ≈ $5.71 Billion |
0.262x | +2.16% |
| 2012-04-30 | €17.11 Billion ≈ $20.01 Billion |
€4.38 Billion ≈ $5.12 Billion |
0.256x | +9.27% |
| 2011-04-30 | €15.97 Billion ≈ $18.67 Billion |
€3.74 Billion ≈ $4.37 Billion |
0.234x | -17.03% |
| 2010-04-30 | €14.63 Billion ≈ $17.10 Billion |
€4.13 Billion ≈ $4.83 Billion |
0.282x | -6.42% |
| 2009-04-30 | €12.85 Billion ≈ $15.02 Billion |
€3.88 Billion ≈ $4.53 Billion |
0.302x | -0.22% |
| 2008-04-30 | €11.54 Billion ≈ $13.49 Billion |
€3.49 Billion ≈ $4.08 Billion |
0.302x | +11.44% |
| 2007-04-30 | €10.98 Billion ≈ $12.83 Billion |
€2.98 Billion ≈ $3.48 Billion |
0.271x | +15.35% |
| 2006-04-30 | €9.38 Billion ≈ $10.97 Billion |
€2.21 Billion ≈ $2.58 Billion |
0.235x | -12.80% |
| 2005-04-30 | €10.45 Billion ≈ $12.22 Billion |
€2.82 Billion ≈ $3.30 Billion |
0.270x | -13.94% |
| 2004-04-30 | €9.08 Billion ≈ $10.61 Billion |
€2.85 Billion ≈ $3.33 Billion |
0.314x | +19.28% |
| 2003-04-30 | €7.91 Billion ≈ $9.24 Billion |
€2.08 Billion ≈ $2.43 Billion |
0.263x | +6.30% |
| 2002-04-30 | €6.43 Billion ≈ $7.52 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.247x | -25.62% |
| 2001-04-30 | €5.51 Billion ≈ $6.44 Billion |
€1.83 Billion ≈ $2.14 Billion |
0.332x | +43.29% |
| 2000-04-30 | €4.49 Billion ≈ $5.25 Billion |
€1.04 Billion ≈ $1.22 Billion |
0.232x | +86.22% |
| 1999-04-30 | €3.65 Billion ≈ $4.27 Billion |
€455.30 Million ≈ $532.29 Million |
0.125x | -56.84% |
| 1998-04-30 | €2.04 Billion ≈ $2.39 Billion |
€590.10 Million ≈ $689.89 Million |
0.289x | +8.73% |
| 1997-04-30 | €1.75 Billion ≈ $2.04 Billion |
€463.60 Million ≈ $542.00 Million |
0.265x | -5.09% |
| 1996-04-30 | €1.79 Billion ≈ $2.09 Billion |
€500.50 Million ≈ $585.14 Million |
0.280x | -3.56% |
| 1995-04-30 | €1.33 Billion ≈ $1.56 Billion |
€387.20 Million ≈ $452.68 Million |
0.290x | -14.39% |
| 1994-04-30 | €1.05 Billion ≈ $1.23 Billion |
€356.90 Million ≈ $417.25 Million |
0.339x | -2.20% |
| 1993-04-30 | €841.50 Million ≈ $983.80 Million |
€291.50 Million ≈ $340.79 Million |
0.346x | +82.24% |
| 1992-04-30 | €796.50 Million ≈ $931.19 Million |
€151.40 Million ≈ $177.00 Million |
0.190x | +2.58% |
| 1991-04-30 | €683.20 Million ≈ $798.73 Million |
€126.60 Million ≈ $148.01 Million |
0.185x | -6.13% |
| 1990-04-30 | €541.00 Million ≈ $632.49 Million |
€106.80 Million ≈ $124.86 Million |
0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more